...
机译:单独的Nivolumab和Ipilimumab在先前治疗的转移性尿路上皮癌:Checkmate 032 Nivolumab 1 mg / kg加Ipilimumab 3 mg / kg膨胀队列结果
Univ Texas MD Anderson Canc Ctr 1155 Pressler St Unit 1374 Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr 1155 Pressler St Unit 1374 Houston TX 77030 USA;
Ist Nazl Tumori Milan Italy;
Ist Ricovero &
Cura Carattere Sci Ist Oncol Veneto Padua Italy;
START Madrid Ctr Integral Oncol Clara Campal Madrid Spain;
Helsinki Univ Hosp Helsinki Finland;
Duke Univ Med Ctr Durham NC USA;
Fdn G Pascale Ist Nazl Tumori Ist Ricovero &
Cura Carattere Sci Naples Italy;
Hosp Univ 12 Octubre Madrid Spain;
Univ Hosp Bonn Bonn Germany;
Univ Hosp Copenhagen Rigshosp Copenhagen Denmark;
Hosp Clin Barcelona Inst Invest Biomed August Pi i Sunyer Barcelona Spain;
Bristol Myers Squibb Princeton NJ USA;
Bristol Myers Squibb Princeton NJ USA;
Bristol Myers Squibb Princeton NJ USA;
Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;
Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;
机译:单独的Nivolumab和Ipilimumab在先前治疗的转移性尿路上皮癌:Checkmate 032 Nivolumab 1 mg / kg加Ipilimumab 3 mg / kg膨胀队列结果
机译:checkmate-032研究:Nivolumab和Nivolumab加上转移性食管癌患者的疗效和安全性
机译:Nivolumab单疗法和Nivolumab加Ipilemimab在复发性小细胞肺癌中:Checkmate 032随机队列的结果
机译:何时治疗转移性肾细胞癌的组合,全身治疗,以及在转移性肾癌中的活跃监测
机译:单独使用Nivolumab并与伊匹木单抗联合治疗的转移性尿道上皮癌:CheckMate 032 Nivolumab 1 mg / kg加上Ipilimumab 3 mg / kg的扩展研究
机译:Nivolumab单疗法和Nivolumab加Ipilemimab在复发性小细胞肺癌中:Checkmate 032随机队列的结果